Objective. Alexithymia, as a fundamental notion in the diagnosis of psychiatric disorders, is characterized by deficits in emotional processing and, consequently, difficulties in emotion recognition. Traditional tools for assessing alexithymia, which include interviews and self-report measures, have led to inconsistent results due to some limitations as insufficient insight. Therefore, the purpose of the present study was to propose a new screening tool that utilizes machine learning models based on the scores of facial emotion recognition task. Method. In a cross-sectional study, 55 students of the University of Tabriz were selected based on the inclusion and exclusion criteria and their scores in the Toronto Alexithymia Scale (TAS-20). Then, they completed the somatization subscale of Symptom Checklist-90 Revised (SCL-90-R), Beck Anxiety Inventory (BAI) and Beck Depression Inventory-II (BDI-II), and the facial emotion recognition (FER) task. Afterwards, support vector machine (SVM) and feedforward neural network (FNN) classifiers were implemented using K-fold cross validation to predict alexithymia, and the model performance was assessed with the area under the curve (AUC), accuracy, sensitivity, specificity, and F1-measure. Results. The models yielded an accuracy range of 72.7–81.8% after feature selection and optimization. Our results suggested that ML models were able to accurately distinguish alexithymia and determine the most informative items for predicting alexithymia. Conclusion. Our results show that machine learning models using FER task, SCL-90-R, BDI-II, and BAI could successfully diagnose alexithymia and also represent the most influential factors of predicting it and can be used as a clinical instrument to help clinicians in diagnosis process and earlier detection of the disorder.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.
hi@scite.ai
10624 S. Eastern Ave., Ste. A-614
Henderson, NV 89052, USA
Copyright © 2024 scite LLC. All rights reserved.
Made with 💙 for researchers
Part of the Research Solutions Family.